Optimizing clinical monitoring of central nervous system involvement in SLE

Autoimmunity Reviews

Volumn 7, Issue 4, 2008, Pages 297-304

  Castellino, G ^a   Govoni, M ^a   Giacuzzo, S ^a   Trotta, F ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Central nervous system; Neuroimaging; Systemic lupus erythematosus

Indexed keywords

CENTRAL NERVOUS SYSTEM; CLINICAL PRACTICE; HUMAN; NERVE DEGENERATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE DIAGNOSIS; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMIC LUPUS ERYTHEMATOSUS;

BRAIN; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MAGNETIC RESONANCE SPECTROSCOPY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 39549110005     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2007.11.022     Document Type: Review

References (40)

1. McCune W.J., and Golbus J. Neuropsychiatric lupus. Rheum Dis Clin North Am 14 (1988) 149-167
2. ACR ad hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology. Arthritis Rheum 42 (1999) 599-608
3. Mitsias P., and Levine S.R. Large cerebral vessel occlusive disease in systemic lupus erythematosus. Neurology 44 (1994) 385-393
4. Meroni P.L., Tincani A., Sepp N., et al. Endothelium and the brain in CNS lupus. Lupus 12 (2003) 919-928
5. Hess D.C. Cerebral lupus vasculopathy. Mechanisms and clinical relevance. Ann N Y Acad Sci 823 (1997) 154-168
6. Peterson P.L., Axford J.S., and Isenberg D. Imaging in CNS lupus. Best Pract Res Clin Rheumatol 19 (2005) 727-739
7. Abreu M.R., Jakosky A., Folgerini M., Brenol J.C., Xavier R.M., and Kapezinsky F. Neuropsychiatric systemic lupus erythematosus: correlation of brain MR imaging, CT and SPECT. Clin Imaging 29 (2005) 215-221
8. Bosma G.P., Steens S.C.A., Petropoulos H., Admiral-Behloul F., Van den Haak A., Doornbos J., et al. Multisequence magnetic resonance imaging study of neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 50 (2004) 3195-3202
9. Sibbitt W.L., Sibbitt R.R., and Brooks W.M. Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 42 (1999) 2026-2038
10. Jennings J.E., Sundgren P.C., Attwood J., McCune J., and Maly P. Value of MRI of the brain in patients with systemic lupus erythematosus and neurologic disturbance. Neuroradiology 46 (2004) 15-21
11. Csepany T., Bereczki D., Kollar J., Sikula J., Kiss E., and Csiba L. MRI findings in central nervous system systemic lupus erythematosus are associated with immunoserological parameters and hypertension. J Neurol 250 (2003) 1348-1354
12. Roldan C.A., Gelgand E.A., Qualls C.R., and Sibbitt W.L. Valvular heart disease is associated with nonfocal neuropsychiatric systemic lupus erythematosus. J Clin Rheumatol 12 (2006) 3-10
13. Govoni M., Castellino G., Padovan M., Borrelli M., and Trotta F. Recent advances and future perspective in neuroimaging in neuropsychiatric systemic lupus erythematosus. Lupus 13 (2004) 149-158
14. Otte A., Weiner S.M., Peter H.H., et al. Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study. Eur J Nucl Med 24 (1997) 787-791
15. 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinical manifestations. Eur J Nucl Med 22 (1995) 17-24
16. Lin W.J., Wang S.J., Yen T.C., and Lan J.L. Technetium 99-m-HMPAO brain SPECT in systemic lupus erythematosus with CNS involvement. J Nucl Med 38 (1997) 1112-1115
17. Oku K., Atsumi S., Furukawa T., Horita Y., Sakai Y., Jodo S., Amasaki Y., Ichikawa K., Amengual O., and Koike T. Cerebral imaging by magnetic resonance imaging and single photon emission computed tomography in systemic lupus erythematosus with central nervous system involvement. Rheumatology 42 (2003) 773-777
18. Zhang X., Zhu Z., Zhang F., Shu H., Li F., and Dong Y.i. Diagnostic value of single photon emission computed tomography in severe central nervous system involvement of Systemic lupus erythematosus: a case control study. Arthritis Rheum 53 (2005) 845-849
19. Yuh W.T.C., Ueda T., and Male Y.J.E. Perfusion and diffusion imaging: a potential tool for improved diagnosis of CNS vasculitis. AJNR 20 (1998) 87-89
20. Yuh W.T.C., Ueda T., and Male Y.J.E. Diagnosis of microvasculopathy in CNS vasculitis: value of perfusion and diffusion imaging. J Magn Reson Imaging 10 (1999) 310-313
21. Rovaris M., Viti B., Ciboddo G., et al. Brain involvement in systemic immune mediated diseases: magnetic resonance and magnetisation transfer imaging study. J Neurol Neurosurg Psychiatry 68 (2000) 170-177
22. Bosma G.P.T.h., Rodd M.J., Zwindeman A.H., et al. Evidence of central nervous system damage in patients with neuropsychiatric systemic lupus erythematosus, demonstrated by magnetization transfer imaging. Arthritis Rheum 43 (2000) 48-55
23. Steens S.C., Admiraal-Behloul F., Bosma G.P., et al. Selective gray matter damage in neuropsychiatric lupus. Arthritis Rheum 50 (2004) 2877-2881
24. Bosma G.P., Middlekoop H.A., Rood M.J., Bollen E.L., Huizinga T.W., and van Buchem M.A. Association of global brain damage and clinical functioning in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 46 (2002) 2665-2672
25. Bosma G.P., Steens S.C., Petropoulos H., et al. Multisequence magnetic resonance imaging study of neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 50 (2004) 3195-3202
26. Steens SC, Bosma GP, Steup-Beekman GM, Le Cessie S, Huizinga TW, van Buchem MA. Association between microscopic brain damage as indicated by magnetization transfer imaging and anticardiolipin antibodies in neuropsychioatric lupus. Arthritis Res Ther 2006; 8 (2): R38. Electronic publication 2006 Jan 16.
27. Emmer B.J., Steens S.C., Steup-Beekam G.M., et al. Detection of change in CNS involvement in neuropsychiatric SLE: a magnetization transfer study. J Magn Reson Imaging 24 (2006) 812-816
28. Bosma G.P., van Buchem M.A., Rood M.J., et al. Comparison of ADC histograms of patients with neuropsychiatric systemic lupus erythematosus and healthy volunteers. Proc Int Soc Magn Res Med 8 (2000) 1244
29. Moritani T., Shrier D.A., Numaguchi Y., et al. Diffusion-weighted echoplanar MR imaging of CNS involvement in systemic lupus erythematosus. Acad Radiol 8 (2001) 741-753
30. Jennings J.E., Sundgren P.C., Attwood J., McCune J., and Maly P. Value of MRI of the brain in èatients with SLE and neurologic disturbance. Neuroradiology 46 (2004) 15-21
31. Welsh R.C., Rahbar H., Foerster B., Thurnher M., and Sundgren P. Brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus with new acute neurological symptoms. J Magn Reson Imaging 26 (2007) 541-551
32. Iguchi Y., Kimura K., Inoue T., Ueno Y., and Sunada Y. Diffusion weighted magnetic resonance images in a patient with neuropsychiatric lupus. J Clin Neurosci 14 (2007) 273-275
33. Krishnamoorthy K.S., Soman T.B., Takeoka M., and Schaefer P.W. DWI in neonatal cerebral infarction: clinical utility and follow up. J Child Neurol 15 (2000) 592-602
34. Colamussi P., Trotta F., Ricci R., Cittanti C., Govoni M., Barbarella G., Giganti M., et al. Brain perfusion SPECT and proton magnetic resonance spectroscopy in the evaluation of two systemic lupus erythematosus patients with mild neuropsychiatric manifestations. Nucl Med Common. 18 (1997) 269-273
35. Chinn R.J.S., Wilkinson I.D., Hall-Craggs M.A., et al. Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus. Arthritis Rheum 40 (1997) 36-46
36. Sibbitt Jr. W.L., Haseler L.J., Griffey R.R., et al. Neurometabolism of active neuropsychiatric lupus determined with proton MR spectroscopy. Am J Neuroradiol 18 (1997) 1271-1277
37. Brooks W.M., Jung R.E., Ford C.C., et al. Relationship between neurometabolite derangement and neurocognoitive dysfunctionin systemic lupus erythematosus. J Rheumatol 26 (1999) 81-85
38. Appenzeller S., Costallat L.T., Li L.M., and Cendes F. Magnetic resonance spectroscopy in the evaluation of central nervous system manifestations of SLE. Arthritis Rheum 55 (2006) 807-811
39. Castellino G., Govoni M., Padovan M., Colamussi P., Borrelli M., and Trotta F. Proton magnetic resonance spectroscopy may predict future brain lesions in SLE patients: a functional multi-imaging approach and follow up. Ann Rheum Dis 64 (2005) 1022-1027
40. Bertsias J.K., Ioannidis J.P.A., Boletis J., et al. EULAR recommendations for the management of systemic lupus erythematosus (SLE). Report of a task force of the European standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis (5 Jul 2007) (Electronic publication ahead of print)